When does CASI Pharmaceuticals, Inc. report earnings?
CASI Pharmaceuticals, Inc. reports earnings every quartal, last CASI Pharmaceuticals, Inc. earnings report date was 31/03/2021.
How much is CASI Pharmaceuticals, Inc. earnings per share?
CASI Pharmaceuticals, Inc. estimated earnings per share was -0.11 $ last time.
When is CASI Pharmaceuticals, Inc. next earnings report?
Next CASI Pharmaceuticals, Inc. earnings call will be in June 2024.
CASI Pharmaceuticals, Inc. earnings per share - the financial characteristics of the company on the size of its value. Earnings per share are calculated according to the formula: the amount of the company's profit for the financial period according to official reports is divided by the number of shares in the company. Obviously, CASI Pharmaceuticals, Inc. earnings per share is a variable indicator for a specific financial period. Profit of CASI Pharmaceuticals, Inc. - the entire profit of the company in the reporting period.
|
CASI Pharmaceuticals, Inc. earnings report
Profits for the entire company CASI Pharmaceuticals, Inc. is more important to managing managers than shareholders of the company. Shareholders are more interested in earnings per share. It primarily affects the received dividends on shares. The date of the profit report CASI Pharmaceuticals, Inc. is tied to the legislation of the country of registration of the company. The dates of CASI Pharmaceuticals, Inc. profit statements for recent periods are shown in the table and graph of our online service.
|
CASI Pharmaceuticals, Inc. quarterly earnings
Earnings per share CASI Pharmaceuticals, Inc. is calculated by dividing net income by the number of shares in the company. Earnings per share of CASI Pharmaceuticals, Inc. is considered for a certain financial period as well as financial reports on the company's total profit are issued. CASI Pharmaceuticals, Inc. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit CASI Pharmaceuticals, Inc. is the most common type of financial report for financial analytics.
|
|
CASI earnings date
|
Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
|
Change for a year %
|
|
31/03/2021 |
-0.11 USD |
- |
|
31/12/2020 |
-0.12 USD |
- |
|
30/09/2020 |
-0.14 USD |
+40% ↑ |
|
30/06/2020 |
-0.09 USD |
-43.75% ↓ |
|
30/09/2019 |
-0.1 USD |
-63.636% ↓ |
|
30/06/2019 |
-0.16 USD |
-22.222% ↓ |
|
31/03/2019 |
-0.09 USD |
-22.222% ↓ |
|
31/12/2018 |
-0.1 USD |
-75% ↓ |
|
30/06/2018 |
-0.07 USD |
-14.286% ↓ |
|
31/03/2018 |
-0.05 USD |
-28.571% ↓ |
|
31/12/2017 |
-0.08 USD |
-71.429% ↓ |
|
30/09/2017 |
-0.03 USD |
-50% ↓ |
|
31/12/2016 |
-0.05 USD |
-57.143% ↓ |
|
30/09/2016 |
-0.03 USD |
-12.5% ↓ |
|
31/03/2016 |
-0.04 USD |
- |
|
31/12/2015 |
-0.05 USD |
- |
|
30/09/2015 |
-0.05 USD |
-87.273% ↓ |
|
30/06/2015 |
-0.06 USD |
- |
|
30/06/2009 |
-0.44 USD |
- |
|
31/03/2009 |
-0.44 USD |
-100% ↓ |
|
31/12/2008 |
-0.44 USD |
-100% ↓ |
|
30/09/2008 |
-0.44 USD |
-28.571% ↓ |
|
30/06/2008 |
-1.21 USD |
-100% ↓ |
|
31/03/2008 |
-1.1 USD |
-16.667% ↓ |
|
31/12/2007 |
-0.55 USD |
-33.333% ↓ |
|
30/09/2007 |
-0.44 USD |
-12.5% ↓ |
|
30/06/2007 |
-1.1 USD |
- |
|
31/03/2007 |
-0.99 USD |
-16.667% ↓ |
|
31/12/2006 |
-0.88 USD |
-50% ↓ |
|
30/09/2006 |
-0.55 USD |
-37.5% ↓ |
|
30/06/2006 |
-0.99 USD |
-23.0769% ↓ |
|
31/03/2006 |
-5.83 USD |
-16.667% ↓ |
|
31/12/2005 |
-0.55 USD |
- |
|
30/09/2005 |
-0.99 USD |
- |
|
30/06/2005 |
-0.99 USD |
-13.333% ↓ |
|
31/03/2005 |
-1.43 USD |
-7.692% ↓ |
|
31/12/2004 |
-0.22 USD |
-75% ↓ |
|
30/09/2004 |
-0.99 USD |
-100% ↓ |
|
30/06/2004 |
-1.32 USD |
- |
|
31/03/2004 |
-1.54 USD |
- |
|
31/12/2003 |
-1.98 USD |
-42.857% ↓ |
|
30/09/2003 |
-1.65 USD |
-70.588% ↓ |
|
30/06/2003 |
-2.09 USD |
-100% ↓ |
|
31/03/2003 |
-1.76 USD |
-100% ↓ |
|
31/12/2002 |
-0.77 USD |
- |
|
30/09/2002 |
-5.94 USD |
- |
|
30/06/2002 |
-5.61 USD |
- |
|
31/03/2002 |
-7.37 USD |
- |
CASI Pharmaceuticals, Inc. quarterly earnings per share are the estimated profitability of the company. They have intermediate significance among analysts. But annual earnings per share are of primary importance. Last quarterly profit CASI Pharmaceuticals, Inc. for today implies published profit for the last reference quarter. Change in profit CASI Pharmaceuticals, Inc. for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. A change in CASI Pharmaceuticals, Inc. quarterly profit for the year is not so important as a change in CASI Pharmaceuticals, Inc. annual profit compared to last year.
The change in profit is shown as a percentage. The profit history of CASI Pharmaceuticals, Inc. for the past years and reporting periods is in the table “Quarterly profit”. CASI Pharmaceuticals, Inc. quarterly earnings history database is visible online over the past decade. CASI Pharmaceuticals, Inc. online profit database for past time intervals is compiled from verified official sources throughout the entire time.
|
